Microvascularization and angiogenic activity of equine corpora lutea throughout the estrous cycle by Ferreira-Dias, G. et al.
Domestic Animal Endocrinology 30 (2006) 247–259
Microvascularization and angiogenic
activity of equine corpora lutea throughout
the estrous cycle
G. Ferreira-Dias a,∗, P. Pinto Bravo b, L. Mateus a,
D.A. Redmer c, J.A. Medeiros d
a CIISA, Faculdade de Medicina Veterina´ria, R. Prof. Cid dos Santos,
1300-477 Lisboa, Portugal
b Escola Superior Agra´ria de Coimbra, Bencanta, Coimbra, Portugal
c Department of Animal and Range Sciences, North Dakota State University, Fargo, ND, USA
d Faculdade de Medicina, Universidade de Coimbra, Instituto de Fisiologia,
3004-504 Coimbra, Portugal
Received 20 April 2005; received in revised form 19 July 2005; accepted 22 July 2005
Abstract
Corpus luteum growth and endocrine function are closely dependent on the formation of new cap-
illaries. The objectives of this study were to evaluate (i) tissue growth and microvascular development
in the equine cyclic luteal structures; (ii) in vitro angiogenic activity of luteal tissues in response to
luteotrophic (LH, PGE2) and luteolytic (PGF2) hormones and (iii) to relate data to luteal endocrino-
logical function. Our results show that microvascular density was increased in the early and mid luteal
phase, followed by a fall in the late luteal phase and a further decrease in the corpus albicans. Hyper-
plasia of luteal tissue increased until the mid luteal phase and it was followed by tissue regression.
Luteal explants were cultured with no hormone added, or with PGF2, LH, PGE2, LH + PGE2 or
LH + PGF2. Media conditioned by equine luteal tissue from different stages of the luteal phase were
able to stimulate mitogenesis of bovine aortic endothelial cells (BAEC), suggesting the presence of
angiogenic activity. No difference was observed among luteal structures on their mitogenic capacity,
for any treatment used. Nevertheless, Late-CL conditioned-media with PGF2 showed a significant
decrease in BAEC proliferation (p < 0.05) and LH + PGF2 a tendency to reduce mitogenesis. Thus,
prostaglandin F2 may play a role on vascular regression of the CL during the late luteal phase in the
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mare. These data suggest that luteal angiogenesis and vascular regression in the mare are coordinated
with the development of non-vascular tissue and might be regulated by many different factors.
© 2005 Elsevier Inc. All rights reserved.
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1. Introduction
The formation of luteal structures is characterized by repeating patterns of cellular prolif-
eration [1], remodeling of extracellular matrix [2,3] and changes in luteal vascularity in each
ovarian cycle [4]. Many aspects of cyclic changes in the reproductive tract during ovarian
cyclicity, implantation, as well as placental function are dependent on physiologic angio-
genesis [5–8], which consists of new vascular growth from pre-existing vasculature [9].
This neovasculature is essential for the blood-borne delivery of substrates for steroidogenic
cells within the ovary, and enables progesterone (P4) to be released into the blood stream
[10–12]. Tissue growth and regression that occurs in the female reproductive tract appears
to be controlled by stimulating or angiogenic/mitogenic substances and by inhibitory or
anti-angiogenic/anti-mitogenic growth factors [13–17].
The understanding of the vital, angiogenic processes that occur in the mare’s reproductive
tract is lacking. Only in the recent past, studies on microvascularization of the mare’s
reproductive tract, such as the endometrium, follicles and corpus luteum have been carried
out [18–21]. As the corpus luteum (CL) growth and its endocrine function are closely
dependent on the formation of new capillaries, their dysfunction might be related to a
deficient vascularization. In the future, knowledge of this process might help understanding
infertility in the mare due to primary luteal function impairment.
Hormonal regulation of the production of angiogenic factors by the CL has been evaluated
in vitro [22,23]. It is well documented that luteininzing hormone (LH) and prostaglandin
(PG) E2 are the main luteotrophic hormones, while prostaglandin F2, is luteolytic in
nature [24]. Lately, there is growing evidence that besides the main endocrine hormone
LH, a number of locally produced regulators, such as growth factors, peptides, steroids and
prostaglandins, modulate the response of the CL to these endocrine signals [25].
The objectives of this study were to evaluate (i) luteal tissue growth and microvascular
development in the equine cyclic luteal structures; (ii) in vitro angiogenic activity of luteal
tissues in response to luteotrophic (LH, PGE2) and luteolytic (PGF2) hormones and (iii)
to relate data to luteal endocrinological function.
2. Materials and methods
2.1. Animals
During the equine breeding season, from the Spring equinox until the end of August,
luteal tissue and blood were collected post-mortem at a slaughter facility from randomly
designated cycling mares. Mares’ reproductive and clinical histories were unknown, but
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they were in good physical condition as determined by veterinary inspection.
2.2. Collection and classification of luteal tissues
Luteal tissue was obtained from the ovaries of 37 mares immediately after slaughter.
Ovaries and ovarian structures were measured. Luteal structures were classified based on
their macroscopic aspect as: early structures (corpora hemorrhagica, CH); mid-luteal phase
(corpora lutea associated with follicles 15–20 mm in diameter; Mid-CL); late-luteal phase
(corpora lutea associated with follicles 30–35 mm in diameter, Late-CL) and corpora albi-
cans (CA).
Since luteal tissue was collected from mares of unknown reproductive history, their
estrous cycle determination was based on post-mortem observation of the internal genitalia
and further P4 analysis. Blood samples (10 ml) were collected from the jugular vein into
heparinized tubes (monovettes® Sarstedt, Numbrecht, Germany) and transported on ice to
the laboratory. Plasma obtained by blood centrifugation was kept frozen (−20 ◦C) until
progesterone assays were performed. Mares were considered to be in the luteal phase when
their plasma P4 concentration was >1 ng/ml, a CL was present. Mares in the follicular
phase presented follicles >35 mm in diameter, plasma P4 was <1 ng/ml, corpora albicans
were usually present and CL were absent.
2.3. Experiment I—in situ study
Luteal tissue was fixed in Carnoy solution for 6 h, dehydrated in a series of ethanol
dilutions, infiltrated in xylene and embedded in paraffin for histological studies and deter-
mination of vascular areas (CH, n = 7; Mid-CL, n = 17; Late-CL n = 8; CA, n = 5). Other
pieces of tissue were transported, on dry ice, to the laboratory and kept at −70 ◦C, until
DNA, RNA and protein determinations were performed (CH, n = 7; Mid-CL, n = 17; Late-
CL n = 8; CA, n = 5).
2.4. Experiment II—in vitro study
In order to evaluate the angiogenic activity of equine corpora lutea throughout the estrous
cycle, small samples of corpora lutea (CH, n = 5; Mid-CL, n = 7; Late-CL, n = 7) were
rinsed thrice in sterile PBS with penicillin and streptomycin, and transported, on ice, to the
laboratory in culture medium for further incubation and endothelial cells mitogenesis assays.
Medium consisted of Earle’s Balanced Salts medium with Hepes (25 mM), streptomycin
(100g/ml) and penicillin (100 U.I./ml)(all reagents from Sigma, St. Louis, MO, USA)
added. Corpora albicans were not used in this part of the experiment due to lack of available
tissue.
Luteal tissue was minced into small (approximately 1 mm3, 200 mg/3 ml) explants
(CH = 5; Mid-CL = 7, Late CL = 7) and pre-incubated for 1 h in polystyrene culture tubes
(Sarstedt, Numbrecht, Germany), in a tissue incubator (Biosafe Eco-Integra Biosciences,
Chur, Switzerland; 37 ◦C, 5% CO2, 95% air), on a shaker (Titertek; Huntsville, AL, USA;
150 rpm). The culture medium consisted of DMEM and Ham’s F12 (1:1, v/v), and was
supplemented with BSA (4 mg/ml, Sigma), transferrin (5g/ml; Sigma), hidrocortisone
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(40 ng/ml, Sigma), insulin (5g/ml, Sigma), penicillin (50 U/ml, Sigma) and streptomycin
(50g/ml, Sigma). After the pre-incubation period, luteal explants were further incubated
for 6 h with (1) no hormone, (2) LH (1g USDA-bs/ml, Sigma), (3) PGF2 (1g/ml,
Upjohn), (4) PGE2 (1g/ml, Sigma) and (5) LH + PGE2 (1g/ml each) or LH + PGF2
(1g/ml each). These hormonal concentrations have been previously tested on in vitro
bovine luteal tissue incubations for endothelial cells mitogenesis assays [23]. For control,
both media with or without hormones added were incubated in the absence of tissue. Media
from negative controls and conditioned by luteal tissues were stored at −70 ◦C, to be later
tested for P4 production and for their ability to stimulate mitogenesis of bovine aortic
endothelial cells (BAEC).
2.5. Determination of vascular areas
Six-micrometer-thick luteal tissue sections were cut with a rotatory microtome (Leica®
RM2125RT, Leica Instruments, Nubloch, Germany) and walls of blood vessels were
marked using Periodic Acid Shiff reagent (PAS)(Sigma). This reagent strongly reacts
with carbohydrates in the microvascular basement membrane and has been widely used
as a marker of endothelial cells [26]. For each mare, number of vessels and microvas-
cular areas were determined on histologic sections, on 10 randomly chosen micro-
scope fields, using a light microscope at a total magnification of 400×, connected to
a computerized cell analysis system (CAS, Becton & Dickinson, Erembodegem, Bel-
gium). All blood vessels in luteal tissue were evaluated equally without distinguish-
ing their nature (arterioles, venules and capillaries). Vascular area was calculated as
the percentage of the area occupied by blood vessels with respect to the total area
in each microscopic field on all 10 histologic sections evaluated per each mare. Ves-
sel numbers were also counted on the same histologic sections used for microvascular
area determination. Total vascular area and blood vessels number were determined as
the mean values for all 10 microscopic fields of the luteal tissue evaluated for each
mare.
2.6. Determination of total DNA, RNA and protein content
To assess cellular growth and regression of equine luteal tissues, concentrations of
genomic DNA, RNA and protein were analyzed. Samples (100 mg) of luteal tissue were
placed in 1.2 ml of digestion buffer (100 nM NaCl, 10 mM Tris–Cl, pH 8, 25 mM EDTA, pH
8, 0.5% sodium dodecyl sulfate, 0.1 mg/ml proteinase K) and ground by use of a polytron
(Ultraturrax T8, IKA® Werke, Staufen, Germany) at 4 ◦C. Nucleic acids were extracted
with phenol/chloroform/isoamyl alcohol, and DNA was purified as described elsewhere
[27]. For total RNA extraction, luteal tissue (100 mg) was also ground with a polytron in
1 ml of Trizol (Sigma), then separated by using chloroform and centrifugation. RNA was
precipitated from the aqueous phase with isopropyl alcohol. After a 10 min incubation at
room temperature, followed by a 10 min centrifugation (12,000 × g, 4 ◦C), the pellet was
washed with 70% ethanol in Trizol and redissolved in DPEC water (Sigma). Quantification
of nucleic acids was achieved on the basis of optical density of the sample using a UV
photometer (Ultrospec 3100 Pro, Amersham Pharmacia Biotech, Piscataway, NJ, USA)
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operated at a wavelength of 260 nm.
Protein determination was performed on sample homogenates by using the Coomassie
Plus protein assay (Pierce Chemical Co., Rockford, IL, USA). Bovine serum albumin was
used as a standard. Luteal tissue hyperplasia was indicated by cell content of DNA [6,28].
Ratios of RNA:DNA and protein:DNA were considered to be an index of tissue hypertrophy
[6,28].
2.7. Endothelial cells mitogenesis assay
The ability of equine luteal tissue conditioned media to stimulate mitogenesis of bovine
aortic endothelial cells was studied as described by Redmer et al. [23]. Vascular endothelial
growth factor (VEGF; Sigma) was used as a positive control, at different concentrations
(10, 20, 25 and 50 ng/ml). The positive control was used to evaluate the ability of an
angiogenic factor (VEGF) to stimulate BAEC proliferation under the same experimental
conditions. Briefly, BAEC (2 × 104 cells/ml) were allowed to adhere to the bottom of a
24-well culture plate (Nucleon-Nunc, Ballerup, Denmark), and incubated for 24 h in a
tissue incubator (Biosafe Eco Integra Biosciences, Chur, Switzerland; 37 ◦C, 5% CO2, 95%
air). Afterwards, the conditioned media samples were added in triplicate wells at a final
concentration of 30%, and incubated for another 72 h. Proliferative response of BAEC
to samples was evaluated under the light micoscope (Olympus CK40, Wetzlar-Nauborn,
Germany), by determining the number of cells in each well, using a neubauer chamber and
further compared to controls. For each mare, treatment effects were assessed by comparing
BAEC proliferation in luteal tissue conditioned media with media from negative controls
(with no luteal tissue). Therefore, the percentage of BAEC proliferation in equine luteal
tissue conditioned media was calculated with respect to negative controls, which were
considered 100% of cell mitogenesis.
2.8. Progesterone assays
Progesterone concentration in both plasma and luteal tissue conditioned media was
evaluated using a solid-phase radioimmunoassay (Coat-a-Count Progesterone, Diagnostic
Product Corp., Los Angeles, CA, USA). Intra and inter assay coefficients were, respectively,
6.4% and 18.8% for the level of 3.2 nmol/l (1 ng/ml) and 4.2% and 8.0% for the level of
15.9 nmol/l (5 ng/ml).
2.9. Statistical analysis
Since values regarding microvascular areas on different luteal structures were not nor-
mally distributed, data were subjected to arcsine transformation and analyzed by use of a
one-way ANOVA. Data on blood vessels count per luteal strucuture were also analyzed by
one-way ANOVA. Significance was defined as values of p < 0.05.
Data for DNA, RNA and protein content, RNA:DNA and protein:DNA in 100 mg of
luteal tissue were processed by use of a one-way ANOVA. The same statistical procedure
was used for endothelial cells mitogenesis data and P4 concentration in both plasma and
luteal tissue conditioned media. Significance was defined as values of p < 0.05. Whenever
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a significant difference was detected, post hoc comparison tests (Scheffe´ F-test or Fisher
least-significant difference test) were performed (Statistic for Windows, Statsoft Inc., 1995,
Tulsa, OK, USA).
3. Results
3.1. Determination of vascular areas
Vascular areas were greater during the early luteal phase (CH) and the mid luteal phase
(Mid-CL) than in the Late-CL and CA (p < 0.05; Fig. 1A). Regarding the mean number of
vessels in luteal tissue there was a significant increase during Mid- and Late-CL compared
to CH and CA (p < 0.05; Fig. 1B). Even though the vascular area in the regressed and
afunctional luteal structure (CA) was lower than in the early luteal structure (CH), the
number of blood vessels between both structures did not differ (p > 0.05; Fig. 1B).
3.2. Determination of DNA, RNA and protein
The DNA concentration (Table 1) of early luteal phase structures was much lower than
Mid-CL (p < 0.001)(Table 1). Even though late luteal structures DNA concentration was
not different from early structures, it was lower than observed in the mid luteal phase
CL (p < 0.001). The afunctional luteal structure (CA) showed a reduction in DNA when
Fig. 1. Vascular areas (A) and mean blood vessel number (B) in luteal tissue obtained from mares during the estrous
cycle. Values reported are means ± S.E.M. (a and b) Values differ significantly (p < 0.05, Fisher least significant
test). CH, corpus hemorrhagicum; Mid-CL, corpus luteum from mid luteal phase; Late-CL, corpus luteum from
late luteal phase; CA, corpus albicans.
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Table 1
Concentration of DNA, RNA, protein, RNA:DNA and protein:DNA of luteal tissue obtained from mares during
the estrous cycle
Luteal tissue
Variable CH Mid-CL Late-CL CA
DNA (mg/g of tissue) 29.9 ± 4.8a 56.8 ± 5.5b 29.3 ± 3.5a 17.5 ± 2.5c
RNA (mg/g of tissue) 7.5 ± 4.0d 25.8 ± 5.6e 10.7 ± 3.6d 5.7 ± 0.8d
Protein (mg/g of tissue) 308.2 ± 29.2f 313.2 ± 22.6f 210.1 ± 38.6g 101.6 ± 25.7h
RNA:DNA 0.41 ± 0.2 0.65 ± 0.2 0.34 ± 0.12 0.34 ± 0.07
Protein:DNA 14.1 ± 2.1f 7.4 ± 0.99g 9.0 ± 3.0f,g 5.5 ± 0.9g
Values reported are means ± S.E.M. (a–c) Values differ significantly (p < 0.001). (d and e) Values differ significantly
(p < 0.01). (f–h) Values differ significantly (p < 0.05, Fisher least significant test). CH, corpus hemorrhagicum; Mid-
CL, corpus luteum from mid luteal phase; Late-CL, corpus luteum from late luteal phase; CA, corpus albicans.
compared to all the other luteal structures evaluated (p < 0.0001). Even though RNA con-
centration was much higher in the Mid-CL when compared to CH (p < 0.01), protein
concentration did not differ. In addition, RNA concentration was similar between early,
late CL and CA (p > 0.05), but it was lower than the Mid-CL (Table 1). Furthermore, pro-
tein concentrations were also increased in the early and Mid-CL, and were followed by
a decrease in late luteal structures (p < 0.05). Another fall in protein concentration was
observed in the afunctional luteal structure (p < 0.05; Table 1). Even though protein-DNA
ratio was the highest in the CH when compared to all the other luteal structures (p < 0.05), no
difference was noted on RNA:DNA for any of the other tissue samples evaluated (Table 1).
3.3. Endothelial mitogenesis assays
Equine luteal tissue alone showed the capability to increase BAEC proliferation (Fig. 2),
when compared to negative controls (p < 0.05). However, no difference was observed among
luteal structures on their mitogenic capacity, for any treatment used. Nevertheless, Late-
Fig. 2. Mitogenic capacity of different luteal structures on bovine aortic endotelial cells (BAEC) in the presence or
absence (control) of different hormones. Values reported are means ± S.E.M. (a and b) Values differ significantly
(p < 0.05, Fisher least significant test). CH, corpus hemorrhagicum; Mid-CL, corpus luteum from mid luteal phase;
Late-CL, corpus luteum from late luteal phase.
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Fig. 3. Plasma progesterone (P4) concentrations from mares during different stages of the estrous cycle. Values
reported are means ± S.E.M. (a–c) Values differ significantly (p < 0.05, Fisher least significant test). CH, corpus
hemorrhagicum; Mid-CL, corpus luteum from mid luteal phase; Late-CL, corpus luteum from late luteal phase;
CA, corpus albicans.
CL conditioned media with PGF2 showed a significant decrease in BAEC proliferation
(p < 0.05) and LH + PGF2 a tendency to reduce mitogenesis but did not reach statistical
significance (p = 0.07).
Positive controls showed the ability of the angiogenic factor VEGF to stimulate BAEC
proliferation under the experimental conditions, at different concentrations (10, 20, 25 and
50 ng/ml). Even though there was a 25% increase in BAEC proliferation from 10 ng/ml
(164.4% ± 6) to 20 ng/ml (189.21% ± 5) no further increase was observed for higher doses.
3.4. Progesterone analyses
In this study, the analysis of plasma P4 (Fig. 3) revealed differences in the synthesis of
this hormone by several luteal structures, depending on their nature (i.e. CH, Mid-CL and
Late-CL). There was a significant rise in plasma P4 from CH stage to mid luteal phase CL
(p < 0.01), followed by a fall in the Late-CL (p < 0.05; Fig. 3). Plasma P4 synthesized by
Fig. 4. In vitro progesterone (P4) concentrations in culture medium conditioned by cycling mares’ luteal tissue
in the presence or absence (control) of different hormones. Values reported are means ± S.E.M. CH, corpus
hemorrhagicum; Mid-CL, corpus luteum from mid luteal phase; Late-CL, corpus luteum from late luteal phase.
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early luteal phase CL was not different from the levels produced by late luteal structures
(Fig. 3). In the follicular phase, when the afunctional CA was present in the ovary, plasma
P4 concentration was much lower than in the presence of any other luteal structures in the
luteal phase (p < 0.001).
The release of P4 in culture medium without exogenous hormones, showed a tendency
(p = 0.07) to rise from CH (14.5 ± 2.5 ng/mg of luteal tissue) to Mid-CL (19.1 ± 3.1 ng/mg
of tissue), and to decrease in Late-CL (9.6 ± 3.8 ng/mg of tissue), similar to plasma P4.
Early luteal phase structure showed a 1.7-fold increase (69%) in in vitro P4 secretion, when
in the presence of both luteotrophic hormones tested (LH + PGE2) with respect to control,
even though no significant difference was observed (Fig. 4).
4. Discussion
Changes in microvascularization on equine cyclic luteal structures were present through-
out the luteal phase, suggesting that numerous but not yet defined angiogenic factors are
produced by the equine CL, during luteal development. Mitogenic factors, such as vas-
cular endothelial growth factor, fibroblast growth factor (FGF), angiogenin, angiopoietins,
nitric oxide and monocyte chemottractant protein-1 (MCP-1 factor), among others, promote
endothelial cell proliferation and migration and therefore vascular growth in ovarian tissues
from different species [8,10,11,29–34]. In this study, a marked increase in microvascular
area in the early and mid-luteal phases was observed, even though vessel number was the
highest during mid and late luteal phases. Similar results have been previously reported in
the cow and in the mare [35–37]. In the present study, the high number of blood vessels in
the late CL, associated with a decrease in vascular areas, might be explained by a decrease in
blood vessel lumen and by vessel contraction giving the appearance of concentric rings [36].
This decrease in capillary diameter may lead to a fall in blood flow and could initiate and/or
accelerate CL regression [38]. The further fall in blood vessel density and number observed
in the mare’s CA, might be ascribed to the occlusion of blood vessels that disappear as the
residual luteal structure organizes into the corpus albicans [36].
A rise in DNA content in the mid luteal phase suggests luteal tissue hyperplasia in the
mare. This might be due not only to luteal cells proliferation [39], but also to endothelial
cells proliferation (1). Also, in the cow, ewe and sow, DNA content and rate of DNA
synthesis increased linearly, from early CL until the mature CL was formed [1,40,41].
The decrease in both microvascular areas and DNA content in Late-CL and regressed
luteal structure in the present study suggests that blood vessel regression is associated with
tissue involution that occurs during regression of the luteal structures [35,42]. In addition,
the highest protein:DNA ratio in the early luteal structure suggests hypertrophy of equine
luteal tissue after ovulation. Thus, this could be ascribed to hypertrophy of fibroblasts and
other stromal cells or to the presence of a large amount of red blood cells that lack DNA
[43]. Protein content drop in late luteal phase tissue and in the afunctional luteal structure
suggests luteal regression, which is accompanied by vascular regression.
Plasma P4 concentration was the highest in mares presenting a mature CL, when vascular
areas and blood vessels count were also elevated. Increase in blood supply in the mature
CL as well as P4 secretion was also reported for other species [1,16]. The fall in plasma
256 G. Ferreira-Dias et al. / Domestic Animal Endocrinology 30 (2006) 247–259
P4 concentration in late CL in the present study confirmed the occurrence of functional
luteolysis, followed by structural luteolysis in the CA, when this hormone concentration
falls below basal levels [44]. Actually, in the present study, vascular areas were the highest
during early and mid-luteal stages, and fell afterwards, when P4 secretion also dropped. A
decrease in plasma P4 concentration coinciding with a fall in the density of blood vessels
and endothelial cell proliferation during early luteolysis has been reported in primates [8].
In vitro P4 production by equine luteal tissues in this study shows the incubation adequacy
for the maintenance of normal luteal function [23]. In several animal species, luteal cells
in vitro were able to secrete P4 in response to LH [45,46]. Luteinizing hormone, alone or
in combination with PGF2, was capable of stimulating P4 secretion from bovine luteal
cells in vitro in mid and late luteal phases, but not from early CL [46,47]. Nevertheless,
other studies showed that bovine and equine CL were not responsive to LH in vitro [48,49],
which is in agreement with our observations.
All equine luteal structures from different stages of the luteal phase showed in vitro angio-
genic activity by stimulating the proliferation of endothelial cells, as previously described
for the cow [23]. As a matter of fact, endothelial cells used here were from bovine aorta
and not from equine specific endothelial cells. However, a number of physiologic func-
tions, such as the secretion of PGI2 and ET-1 are shared by all endothelial cells [50,51]. As
reported for the cow [22], these data show that LH did not cause a significant increase in
angiogenic activity by any equine luteal structure evaluated. However, there is substantial
evidence that luteal angiogenesis is hormonally regulated by luteinizing hormone (LH) as
most of the major potential regulatory factors are produced by lutein cells, which respond
to changing LH stimulation [52]. Neither any stimulatory effect on BAEC was observed
for any luteal structures when in the presence of PGE2 (a luteotrophic hormone in other
species). However, when the regressing luteal structure was in the presence of a luteolytic
hormone (PGF2), a decrease in mitogenic activity was observed. Also, when PGF2 was
combined to LH, there was a tendency to reduce BAEC mitogenesis, when compared to
controls. On the contrary, conditioned media from Late-CL in the cow exerted the greatest
angiogenic response when compared to media conditioned by mid-cycle or corpora hemor-
rhagica [23]. In another study, the expression of the angiogenic factor FGF-2 was increased
during functional luteolysis and decreased afterwards in the bovine corpus luteum [44]. The
decrease in endothelial cell mitogenesis observed in mare’s late CL when in the presence of
PGF2, could be due not only to a lack of synthesis of angiogenic factors, but also to a rise in
anti-angiogenic factors, such as angiostatin, endostatin [53,54], thrombospondins [55] and
platelet factor 4 [56], which may be modulating angiogenesis and luteal regression. Some
anti-angiogenic factors might be involved in luteal formation to avoid excessive vascular
development and to mediate endothelial cells apoptosis during regression [9]. Thus, accord-
ing to our results, PGF2 may play a role in vascular regression of the CL during the late
luteal phase in the mare. However, in the cow, a paracrine role for PGF2 on proliferation
and survival of bovine derived endothelial cells has been recently reported [57]. Morpho-
logical alterations of both steroidogenic cells and blood vessels are essential for regression
of cyclic CL [8], with microvascular endothelial cells being the first ones to undergo apop-
tosis [58]. Since in the mare, overall apoptosis also increases in the late luteal phase CL
[59,60], it makes sense that in this study vascular regression was also increased in this stage
of the luteal phase, as shown by a decrease in both microvascular areas and endothelial cell
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mitogenesis under the influence of PGF2. In conclusion, vascular growth and regression
appear to be coordinated with development of non vascular tissue. Also, PGF2 may play
a role on vascular regression, acting on endothelial cells during the late luteal phase. These
data suggest that luteal angiogenesis and vascular regression in the mare is a very complex
process that might be regulated by many different factors and needs further investigation.
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